• BSE
  • NSE
Partner with US Open an Demat Account EIPO Portfolio Tracker Watsapp Play Store App Store

News Details

27/01/2026 12:36

Alembic Pharmaceutic - Press Release

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated January 27, 2026, titled ""Alembic Pharmaceuticals Limited receives USFDA Final Approval for Difluprednate Ophthalmic Emulsion, 0.05%."".